84-2133-35 GDF15 (Growth/Differentiation Factor 15, GDF-15, Placental Bone Morphogenetic Protein, Placental TGF-beta, Macrophage Inhibitory Cytokine 1, MIC-1, Prostate Differentiation Factor, NSAID-activated Gene 1 Protein, NAG-1, NSAID-regulated Gene 1 Protein, NRG-1, MIC1, PDF, PLAB, PTGFB) (HRP) 100ug 168189

※お見積書はカートで印刷できます

冷凍

特徴

  • Non-steroidal anti-inflammatory drug (NSAID) activated gene (NAG-1) is a member of the transforming growth factor-b (TGF-B) superfamily.
  • NAG-1 is also known as macrophage inhibitory cytokine-1(MIC-1), growth differentiation factor 15 (GDF15), placental bone morphogenetic protein (PLAB), or prostate derived factor (PDF).
  • NAG-1 is expressed in human placenta, prostate and colon.
  • It possesses antitumorigenic and proapoptotic activities.
  • NAG-1 expression is dramatically increased in inflammation, injury and malignancy.
  • Increase of NAG-1 expression is a feature of many cancers including breast, colon, pancreas and prostate.
  • In a number of studies, NAG-1 expression was increased by a number of NSAIDs.
  • This increase in expression may correlate with the chemopreventive effect NSAIDs seem to have with certain cancers.
  • NAG-1 expression is also induced by PPAR gamma ligands and by several dietary compounds such as conjugated linoleic acids (CLAs), naturally occurring fatty acids in ruminant food products, indoles, epicatechin gallate, and genistein.
  • Induced expression of NAG-1 results in stimulation of apoptosis and inhibition of cell growth.
  • Inhibition of NAG-1 induced expression by small interference RNA (siRNA) results in repression of induced apoptosis.
  • NAG-1 expression is regulated by a numbers of transcription factors such as ERG-1 and Sp1.
  • EGR-1 may be necessary for NSAID-induced NAG-1 expression.
  • The study of expression of NAG-1 proteins, including variants, is important to define their potential role as serum biomarkers for cancer diagnosis, treatment monitoring, epidemiology study, and nutrition surveys.
  • Applications:Suitable for use in ELISA and Western Blot.
  • Other applications not tested.
  • Recommended Dilution:Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Lyophilized powder may be stored at -20°C.
  • Stable for 12 months at -20°C.
  • Reconstitute with sterile dH2O or PBS.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Reconstituted product is stable for 12 months at -20°C.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
  • Labeled with horseradish peroxidase (HRP).
  • Sodium azide is a potent inhibitor of peroxidase and should not be added to HRP conjugates.
  • HRP conjugates are sensitive to light.

仕様

  • Size:100ug
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by Protein A affinity chromatography.
  • Form:Supplied as a lyophilized powder in 0.02M PBS, pH 7.2, 10mg/ml BSA, 0.01% gentamicin sulfate. Reconstitute with sterile dH2O or PBS. Labeled with horseradish peroxidase (HRP).
  • Specificity:Recognizes human NAG-1. Species Crossreactivity: mouse. Species sequence homology: macaque (94%), rat (70%).
  • Isotype:IgG
  • Calc Applications Abbrev:E WB
  • Calc Crossreactivity:Hu Mo
  • Immunogen:Recombinant protein corresponding to human NAG-1 expressed in E.coli, MBP-tagged.
  • Shelf Life:1year
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-2133-35
型番
168189
入り数
1個
標準価格
219,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る